Cell and Gene Outsourcing

  1. Testing At WuXi Advanced Therapies 3/21/2024

    Learn how a partner offering a comprehensive suite of integrated testing services designed to navigate the complexities of cell and gene therapies is critical for accelerating development timelines.

  2. Overcoming Challenges In AAV And LV Viral Vector Manufacturing 3/21/2024

    Mathias Kahl, Director of Process Development, shares insights on overcoming challenges in AAV and LV viral vector manufacturing.

  3. Accelerated Adventitious Virus Testing In Viral Vector Vaccines 3/21/2024

    Implementing NGS technology for adventitious virus testing in viral vector vaccine development and manufacturing is crucial for ensuring safety. Gain insights for an optimized sequencing method.

  4. Manufacturing GTP And GMP 3/21/2024

    Learn how a one-stop solution for your cell therapy needs can help ensure efficiency, cost-effectiveness, and faster patient treatment. Our Draw-to-Thaw® service streamlines the entire process.

  5. Development And Optimization Of Suspension-Adapted 293T Cell Line 3/21/2024

    Learn how an adapted cell line can reduce costs and improve scalability in the production of lentiviral vectors for CGTs and examine its potential to produce GMP-grade lentiviral vectors.

  6. Navigating Regulatory Challenges For CGT Products In 2024 And Beyond 3/20/2024

    The cell and gene therapy (CGT) regulatory landscape is complex and continuously evolving. Review expert insights based on recent FDA guidance as well as important considerations for CGT development.

  7. How To Promote Batch-To-Batch Consistency In CAR-T Therapies 3/18/2024

    Patient immune cells and varied raw materials introduce inherent biological variability into CAR-T therapy manufacturing, making it a constant balancing act of adjusting processes and technology to minimize batch-to-batch variability.

  8. Spent Media Analysis To Improve Cell Therapy Manufacturing 3/14/2024

    Targeted metabolomics-based PAT allows for metabolic profiling of the T-cells throughout the cell therapy manufacturing process through spent media analysis.

  9. AAV cGMP Manufacturing Located In San Sebastian, Spain 3/13/2024

    Viralgen's AAV manufacturing services are powered by the advanced Pro10™ platform, which has produced over 1000 successful batches of high-quality vectors crucial for gene therapy research.

  10. CTDMO Services To Fast-Track The Advancement Of mRNA-Based Drugs 3/13/2024

    Discover CTDMO services that establish robust, integrated, and consistent processes across all stages, enabling you to fast-track the advancement of your mRNA-based vaccines and therapeutics.